RemeGen Co., Ltd. (SHA:688331)
China · Delayed Price · Currency is CNY 99.68
-0.52 (-0.52%)
At close: Feb 6, 2026
RemeGen Employees
RemeGen had 3,070 employees as of June 30, 2025.
Employees
3,070
Change
n/a
Growth
n/a
Revenue / Employee
742.85K CNY
Profits / Employee
-315.98K CNY
Market Cap
49.49B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 3,070 | - | - |
| Dec 31, 2024 | 2,999 | -616 | -17.04% |
| Dec 31, 2023 | 3,615 | 283 | 8.49% |
| Dec 31, 2022 | 3,332 | 1,211 | 57.10% |
| Dec 31, 2021 | 2,121 | 755 | 55.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharmaron Beijing | 22,908 |
| Asymchem Laboratories (Tianjin) | 9,595 |
| Chongqing Zhifei Biological Products | 7,220 |
| Haisco Pharmaceutical Group | 5,337 |
| Beijing Tiantan Biological Products | 5,298 |
| Beijing Wantai Biological Pharmacy Enterprise | 3,790 |
| Shanghai RAAS Blood Products | 3,350 |
| Xiamen Amoytop Biotech | 2,685 |